Data from one of the quality of life measurements collected from
colorectal cancer patients enrolled in the North Central Cancer Treatment Group
phase III trials N9741. The patient received three treatment regimens:
IFL (irinotecan, bolus fluorouracil, and leucovorin), FOLFOX (infused
fluorouracil, leucovorin, and ocaliplatin), and IROX (irinotecan and oxaliplatin).
Usage
data(appetite)
Format
A data frame with 174 observations on the following 2 variables.
Group
A factor with levels FOLFOXIFLIROX.
Score
A numeric vector containing the appetite scores.
Details
The objective is to test whether there are differences between the treatment regimens
in terms of different appetite scores.
Source
Ryu, E. (2009): Simultaneous confidence intervals using ordinal effect measures for ordered categorical outcomes. Statistics In Medicine, 28(25), 3179-3188.